Search results
Sanofi taps Belharra for immune drug research; AstraZeneca’s new cancer drug falls short
BioPharma Dive via Yahoo Finance· 4 days agoBelharra will use its chemoproteomics technology to identify immune drugs for Sanofi. Elsewhere,...
Sanofi (OTCMKTS:SNYNF) Sees Significant Drop in Short Interest
ETF DAILY NEWS· 6 days agoSanofi (OTCMKTS:SNYNF – Get Free Report) saw a significant drop in short interest in the month of May. As of May 31st, there was short interest totalling 290,700 shares, a ...
Millions of Americans in insulin deserts worry that recent price reductions could one day disappear
KY3 Springfield· 5 days agoCharlene Davis sleeps on her living room floor in Atlanta to help ease her back pain and make it...
How Managing Eczema Became a Slam Dunk for WNBA Star Diana Taurasi
Healthline via AOL· 5 days agoWNBA legend Diana Taurasi (above) is sharing how she learned to manage painful eczema flair-ups....
Diana Taurasi Urges Patience With Caitlin Clark, WNBA Rookie Class: ‘Give These Kids Some Grace’
Us Weekly via Yahoo News· 4 days agoWhile celebrating her historic 20th season in the WNBA, Diana Taurasi is busy looking out for the...
Diana Taurasi Urges Patience With Caitlin Clark, WNBA Rookie Class
US Weekly· 4 days agoTaurasi, 42 — who spoke to Us Weekly to discuss her partnership with with Sanofi and Regeneron —...
EHA 2024: Monoclonal antibodies continue to dominate multiple myeloma treatments
Pharmaceutical Technology via Yahoo Finance· 23 hours agoPositive DREAMM-8 trial results for MM The Phase III DREAMM-8 trial, a head-to-head, open-label,...
Swiss biotech Melodia sings $275M song for Alivexis’ preclinical cathepsin C inhibitor
FierceBiotech· 1 day agoSwitzerland’s Melodia Therapeutics has signed a $275 million biobucks deal to get its hands on...
Acute Sore Throat: When to Reach for the Antibiotics
Medscape· 6 days agoComplicated or uncomplicated, low or high risk, test or no test? Here's the consensus approach to acute sore throat in adults.
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 5 days agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...